Skip to main content
. Author manuscript; available in PMC: 2019 Nov 1.
Published in final edited form as: Expert Opin Drug Discov. 2019 Aug 14;14(11):1161–1174. doi: 10.1080/17460441.2019.1652593

Figure 2.

Figure 2.

Chemical structures of the new generation of azoles VNI and VFV, and old azoles ravuconazole and posaconazole that inhibit the T. cruzi sterol 14 α-demethylase. VNI [20] and VFV [21] are new promising drug candidates in pre-clinical studies, whereas ravuconazole and posaconazole entered unsuccessful clinical trials [139,11].